Dafna Michaelson Jenet
- Democratic
- Senator
- District 21
The act requires all large group health benefit plans to provide coverage for biomarker testing to guide treatment decisions if the testing is supported by medical and scientific evidence. The act defines "biomarker testing" as an analysis of a patient's tissue, blood, or other biospecimen for the presence of an indicator of normal biological processes, pathogenic processes, or pharmacologic responses to a specific therapeutic intervention. The required testing under the act does not include biomarker testing for screening purposes or direct-to-consumer genetic tests. The act requires the commissioner of insurance to implement biomarker testing coverage for all large employer health benefit plans issued or renewed on or after January 1, 2025. To the extent biomarker testing is not in addition to the benefits provided pursuant to the benchmark plan, all individual and small group health benefit plans must provide coverage for biomarker testing. Within 120 days after the act takes effect, the division of insurance (division) shall submit to the federal department of health and human services (HHS) its determination of whether biomarker testing is in addition to essential health benefits and would require state defrayal of costs pursuant to federal law. The division shall implement the requirement for coverage for biomarker testing for individual and small group health benefit plans within 12 months after the earlier of the division receiving confirmation from HHS that biomarker coverage does not require defrayal or more than 365 days passing since the division submitted its determination that defrayal was not necessary. Biomarker testing is subject to the health benefit plan's annual deductibles, copayment, or coinsurance but is not subject to any annual or lifetime maximum benefit limit. APPROVED by Governor June 3, 2024 EFFECTIVE June 3, 2024(Note: This summary applies to this bill as enacted.)
Governor Signed
Sent to the Governor
Signed by the Speaker of the House
Signed by the President of the Senate
Senate Considered House Amendments - Result was to Concur - Repass
House Third Reading Passed - No Amendments
House Second Reading Special Order - Passed with Amendments - Committee
House Committee on Health & Human Services Refer Amended to House Committee of the Whole
Introduced In House - Assigned to Health & Human Services
Senate Third Reading Passed - No Amendments
Senate Second Reading Passed with Amendments - Committee, Floor
Senate Committee on Appropriations Refer Unamended to Senate Committee of the Whole
Senate Committee on Health & Human Services Refer Amended to Appropriations
Introduced In Senate - Assigned to Health & Human Services
Bill Text Versions | Format |
---|---|
Signed Act (06/03/2024) | |
Final Act (05/17/2024) | |
Rerevised (05/05/2024) | |
Revised (05/04/2024) | |
Reengrossed (04/26/2024) | |
Engrossed (04/25/2024) | |
Introduced (02/06/2024) | |
PA2 (05/03/2024) | |
PA1 (04/12/2024) | |
Committee Amendment |
Document | Format |
---|---|
Fiscal Note SA1 (04/19/2024) | |
Fiscal Note FN1 (02/21/2024) | |
Fiscal Note FN2 (04/19/2024) | |
Fiscal Note FN3 (05/03/2024) | |
Fiscal Note FN4 (07/22/2024) |
Data on Open States is updated periodically throughout the day from the official website of the Colorado General Assembly.
If you notice any inconsistencies with these official sources, feel free to file an issue.